Chengdu Pukang Biotechnology Co., Ltd was founded in 2008 and it is located in the national cross-strait science and technology industry development park——Cross-Strait Science and Technology Park, Wenjiang District, Chengdu，specializing in the long-term development of peptide drugs for chronic disease. As a manufacturer, it integrates production, sales, research and development. At present, our company has a research and development center of 2400 square meters, and a production workshop of 1000 square meters. It plans to build a production base of 12,000 square meters with quality system management according to GMP standards. In recent years, Pukang has been audited more than ten times by well-known pharmaceutical companies at home and abroad, and has been recognized.
The main products of our company are high purity single molecular PEG series derivatives, polypeptide long acting drug side chain and its intermediates (including Semaglutide side chain, Liraglutide side chain, Insulin Degludec side chain, long-acting human growth hormone etc.), and short peptide drugs modified side chains (semaglutide dipeptide, tetrapeptide).
Our company is working with innovative pharmaceutical companies to build a platform for research and development of polypeptide long-acting drugs, and is committed to building a systematic and diverse long-acting side chain library, establishing molecular blocks of polypeptide long-acting side chains, and providing various solutions for customers to develop polypeptide long-acting drugs. Our company adheres to the concept of "quality first, technology foremost", to provide global customers with the best products and the best service.